跳至主要内容
临床试验/NCT05012150
NCT05012150进行中(未招募)不适用

A Pilot Study in Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis: The EQuiPP Study

Ohio State University1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2021年1月5日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
32
试验地点
1
主要终点
Chronic Pancreatitis-Specific Quality of Life

研究概览

简要总结

This study is a prospective study designed to assess the effect of pancreatic endotherapy on quality of life, pain levels, pancreatic exocrine function, and endocrine function.

详细描述

Pancreatic endotherapy represents a potential treatment modality for patients with painful chronic pancreatitis. While pancreatic endotherapy is commonly performed, the effect of chronic pancreatitis on patient-centered outcomes remains poorly studied. Furthermore, the effect of endotherapy on pancreatic endocrine and exocrine are largely unknown. This study therefore aims to prospective observe patients with chronic pancreatitis after endotherapy is performed to better understand how it affects patient-centered outcomes such as pain and quality of life and pancreatic function. In doing so, the study also hopes to be able to predict which patients with chronic pancreatitis will benefit from pancreatic endotherapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic Pancreatitis (as defined by the American Pancreatic Association Guidelines)
  • Presence of Pain
  • Referred for pancreatic endotherapy

排除标准

  • Prior pancreatic endotherapy
  • Prior pancreatic surgery
  • Pregnant females
  • Subjects unable to consent
  • Imprisoned individuals

结局指标

主要结局

Chronic Pancreatitis-Specific Quality of Life

时间窗: 12 months post-completion of endotherapy

Quality of life will be primarily assessed using the PANcreatitis Quality of Life Instrument (PANQOLI). Quality of life will be assessed before and after endotherapy (1, 3, 6, and 12 months). This instrument is based on a 0-87 scale with higher scores representing improved quality of life.

Feasibility of Micro-Longitudinal Daily Pain Assessment

时间窗: 30-day post-procedure period

Pain will be assessed using daily pain diaries with the Brief Pain Inventory (BPI). These will be utilized to create short-term pain trajectories for subjects at baseline and post-procedure. This pain inventory includes 9 pain items graded on 0-10 scale with 10 being the worst pain.

次要结局

  • Change in Self-Efficacy(12 months post-completion of endotherapy)
  • Overall Quality of Life(12 months post-completion of endotherapy)
  • Change in Nociceptive Pain(12 months post-completion of endotherapy)
  • Change in Pain Catastrophizing(12 months post-completion of endotherapy)
  • Pancreatic Endocrine Function via HbA1c(12 months post-completion of endotherapy)
  • Insulin Sensitivity(12 months post-completion of endotherapy)
  • Change in Chronic Pancreatitis-specific Pain(12 months post-completion of endotherapy)
  • Change in Neuropathic Pain(12 months post-completion of endotherapy)
  • Quantitative Sensory Testing(The quantitative sensory testing will be assessed only once during the subject's baseline enrollment.)
  • Pancreatic Exocrine Function(12 months post-completion of endotherapy)
  • Insulin Resistance(12 months post-completion of endotherapy)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mitchell Ramsey

Assistant Professor

Ohio State University

研究点 (1)

Loading locations...

相似试验